SEARCH

SEARCH BY CITATION

References

  • Adedoyin M. O., Vicini S. and Neale J. H. (2010) Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model. Mol. Pain 6, 60.
  • Ambrosio M., Zurn A. and Lohse M. (2011) Sensing G protein-coupled protein activation. Neuropharmacology 60, 4551.
  • Bischofberger J. and Schild D. (1996) Glutamate and N-acetylaspartylglutamate block HVA calcium currents in frog olfactory bulb interneurons via a mGluR2/3-like receptor. J. Neurophysiol. 76, 20892092.
  • Chopra M., Yao Y., Blake T. J., Hampson D. R. and Johnson E. C. (2009) The neuroactive peptide N-acetylaspartylglutamate is not an agonist at the metabotropic glutamate receptor subtype 3 of metabotropic glutamate receptor. J. Pharmacol. Exp. Ther. 330, 2129.
  • Fricker A. C., Mok M. H., de la Flor R., Shah A. J., Woolley M., Dawson L. A. and Kew J. N. (2009) Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR. Neuropharmacology 56, 10607.
  • Ghose S., Wroblewska B., Corsi L., Grayson D., DeBlas A. L., Vicini S. and Neale J. H. (1997) NAAG stimulates mGluR3 to regulate expression of the GABA-A alpha-6 subunit in cerebellar granule cells. J. Neurochem. 69, 23262335.
  • Lea P. M., Wroblewska B., Sarvey J. M. and Neale J. H. (2001) β-NAAG rescues LTP from blockade by NAAG in the rat dentate gyrus via the type 3 metabotropic glutamate receptor. J. Neurophys. 85, 10971106.
  • Lee C. C. and Sherman S. M. (2009) Glutamatergic inhibition in sensor neocortex. Cereb. Cortex 19, 22812289.
  • Lodder-Gadaczek J., Becker I., Gieselmann V., Wang-Eckhardt L. and Eckhardt M. (2011) N-Acetylaspartylglutamate synthetase-II synthesizes N-acetylaspartyl-glutamylglutamate. J. Biol. Chem. 286, 1669316706.
  • Losi G., Vicini S. and Neale J. (2004) NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neurons. Neuropharmacology 46, 490496.
  • Nan F., Bzdega T., Pshenichkin S., Wroblewski J. T., Wroblewska B., Neale J. H. and Kozikowski A. P. (2000) Dual function glutamate-related ligands: discovery of a novel, potent inhibitor of glutamate carboxypeptidase II possessing mGluR2 agonist activity. J. Med. Chem. 43, 772774.
  • Neale J. H., Bzdega T. and Wroblewska B. (2000) N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 75, 44352.
  • Neale J. H., Olszewski R. T., Gehl L. M., Wroblewska B. and Bzdega T. (2005) The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends Pharmacol. Sci. 26, 47784.
  • Neale J. H., Olszewski R. T., Zuo D., Janczura K. J., Lavin K. M., Madore J. C., Profaci C. P. and Bzdega T. (2011) Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family. J. Neurochem. 118, 490498.
  • Niswender C. M. and Conn P. J. (2010) Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol. 50, 295322.
  • Schweitzer C., Kratzeisen C., Adam G., Lundstrom K., Malherbe P., Ohresser S., Stadler H., Wichmann J., Woltering T. and Mutel V. (2000) Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki forest virus vectors. Neuropharmacology 39, 17001706.
  • Silva R., Mata L. R., Gulbenkian S., Brito M. A., Tiribelli C. and Brites D. (1999) Inhibition of glutamate uptake by unconjugated bilirubin in cultured cortical rat astrocytes: Role of concentration and pH. Biochem. Biophys. Res. Comm. 265, 6772.
  • Slusher B. S., Vornov J. J., Thomas A. G. et al. (1999) Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat. Med. 5, 1396402.
  • Tsukamoto T., Wozniak K. M. and Slusher B. S. (2007) Progress in the discovery and development of glutamate carboxypeptidase II inhibitors. Drug Discov. Today 12, 76776.
  • Wroblewska B., Wroblewski J. T., Saab O. and Neale J. H. (1993) N-acetylaspartylglutamate inhibits forskolin-stimulated cyclic AMP levels via a metabotropic glutamate receptor in cultured cerebellar granule cells. J. Neurochem. 61, 943948.
  • Wroblewska B., Wroblewski J. T., Pshenichkin S., Surin A., Sullivan S. E. and Neale J. H. (1997) N-Acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 69, 174182.
  • Wroblewska B., Santi M. R. and Neale J. H. (1998) N-Acetylaspartylglutamate activates cyclic-AMP coupled metabotropic glutamate receptors in cerebellar astrocytes. Glia 24, 172180.
  • Wroblewska B., Wegorzewska I. N., Bzdega T., Olszewski R. T. and Neale J. H. (2006) Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes. J. Neurochem. 96, 10717.
  • Yamamoto T., Hirasawa S., Wroblewska B., Zhou J., Grajkowska E., Kozikowski A., Wroblewski J. and Neale J. H. (2004) Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur. J. Neurosci., 20, 483494.
  • Yamamoto T., Saito O., Aoe T., Bartolozzi A., Sarva J., Zhou J., Kozikowski A., Wroblewska B., Bzdega T. and Neale J. H. (2007) Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats. Eur. J. Neurosci. 25, 14758.
  • Yamamoto T., Kozikowski A., Zhou J. and Neale J. H. (2008) Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain. Mol. Pain 4, 31.
  • Zhao J., Ramadan E., Cappiello M., Wroblewska B., Bzdega T. and Neale J. H. (2001) NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance. Eur. J. Neurosci 13, 340346.
  • Zhong C., Zhao X., Van K. C. et al. (2006) NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat. J. Neurochem. 97, 101525.
  • Zhou J., Neale J. H., Pomper M. G. and Kozikowski A. P. (2005) NAAG peptidase inhibitors and their potential for diagnosis and therapy. Nat. Rev. Drug Discov. 4, 10151026.